Protalix Biotherapeutics, Inc.
(NYSE Amex Equities : PLX)

( )
PLX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Servicestothe Health Industry
symbolcompany%chnglast%shortavg$volume
DGXQuest Diagnostics, Inc. 1.45%145.804.7%$194.39m
IQVIQVIA Holdings, Inc. 0.22%249.010.0%$167.53m
LHLaboratory Corp. of America Holdings 0.65%276.062.4%$149.44m
AMEHApollo Medical Holdings, Inc. -3.68%69.380.0%$40.84m
NOTVInotiv, Inc. 0.55%34.470.0%$10.07m
PLXProtalix Biotherapeutics, Inc. 1.23%1.2418.5%$1.20m
NRCNational Research Corp. 1.76%43.410.0%$0.85m
QIPTQuipt Home Medical Corp. -2.39%5.720.0%$0.29m
PMDPsychemedics Corp. -0.43%8.190.7%$0.17m

Company Profile

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.